3,322
Participants
Start Date
May 1, 2020
Primary Completion Date
January 1, 2021
Study Completion Date
January 31, 2021
Eptacog alfa
Recombinant coagulation factor VII activated
Standard of care
Patients have been treated according to local routine clinical practice at the discretion of the treating physician.
Leiden University Medical Center, Leiden
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Herlev Hospital
OTHER
University of Oxford
OTHER
VU University of Amsterdam
OTHER
Leiden University Medical Center
OTHER